|
 |
|
2022 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities
This new 97-country report from VPGMarketResearch.com is available by geographic region, country, market segment, section, or individual test....
|
 |
|
$34500.00 |
| |
|
|
|
2022 Europe Tumor Marker Diagnostics Market: Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities
This new 38-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test....
|
|
|
$24500.00 |
| |
|
|
|
2022 Tumor Markers: Unlocking Mystery of the Genetic Basis of Cancer--Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence
Highlights- Identifies and evaluates major business opportunities emerging in the tumor marker market during the next five years
- Examines trends in the U.S., Europe and Japan
- Reviews current and emerging tumor markers
- Analyzes applications of emerging diagnostic technologies
- Forecasts sales of major tumor markers by country and market segment
- Profiles leading market players and potential entrants
|
|
|
$9500.00 |
| |
|
|
|
2022 Latin America Tumor Marker Diagnostics Market: Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities
This new 22-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test....
|
|
|
$9500.00 |
| |
|
|
|
2022 Asia-Pacific Tumor Marker Diagnostics Market: Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities
This new 17-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test....
|
|
|
$8500.00 |
| |
|
|
|
2022 Tumor Markers in Europe: Market Segment Forecasts and Supplier Shares
This unique report provides information not available from any other published source, including volume, sales, and leading supplier shares by test. This comprehensive five-country report identifies and evaluates major business opportunities emerging in the tumor markers market during the next five years; examines trends in France, Germany, Italy, Spain, and the UK; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers....
|
|
|
$7500.00 |
| |
|
|
|
2022 North America Tumor Marker Diagnostics Market: Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities
This new 3-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test....
|
|
|
$6900.00 |
| |
|
|
|
2022 Middle East Tumor Marker Diagnostics Market: Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities
This new 11-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test....
|
|
|
$6500.00 |
| |
|
|
|
2022 Tumor Markers and Special Chemistry Market: Supplier Shares, Competitive Strategies, Country Segment Forecasts, Innovative Technologies, Instrumentation Review
This new from VPGMarketResearch.com provides analysis of the global tumor markers and special chemistry testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.
|
|
|
$5500.00 |
| |
|
|
|
2022 US Tumor Marker Testing Market Outlook: Innovations, Trends and Opportunities for Suppliers
Highlights - Comprehensive analysis of the US tumor marker testing market.
- Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years....
|
|
|
$3850.00 |
| |
|
|
|
Tumor Markers: US, Europe, Japan--Strategic Profiles of Leading Cancer Diagnostic Reagent and Instrument Suppliers, Country Volume and Sales Forecasts
This report provides estimates of the number of laboratories performing tumor marker assays, as well as test volume and sales forecasts by country. The report also presents strategic analyses of leading current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
|
|
|
$3850.00 |
| |
|
|
|
Tumor Markers, and Strategic Profiles of Leading Reagent and Instrument Suppliers
This report presents comprehensive marketing and technological assessment, as well as medical rationale and diagnostic prospects for major categories of both circulating and cellular tests, such as Biochemical Markers, Oncogenes, Growth Factors, Hormones, Colony Stimulating Factors, Lymphokines, Immunohistochemical Stains and others.
|
|
|
$3850.00 |
| |
|
|
|
2022 Tumor Marker Testing Technologies and Strategic Profiles of Leading Suppliers
This report provides detailed assessments of such technologies as monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their potential applications for tumor markers technologies. Also included is a review of competing/complementing technologies, such as CT, MRI, NMR, PET and photonics spectroscopy.
|
|
|
$3850.00 |
| |
|
|
|
Analysis of the World Tumor Markers Testing Market
Sales Forecasts by Country and Strategic Profiles of Leading Suppliers
This report provides estimates of the number of laboratories performing tumor marker assays, as well as test volume and sales forecasts by country. The report also presents strategic analyses of leading current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
|
|
|
$3500.00 |
| |
|
|
|
2022 Analysis of Emerging Tumor Markers
and Strategic Profiles of Leading Suppliers
This report presents comprehensive marketing and technological assessment, as well as medical rationale and diagnostic prospects for major categories of both circulating and cellular tests, such as Biochemical Markers, Oncogenes, Growth Factors, Hormones, Colony Stimulating Factors, Lymphokines, Immunohistochemical Stains and others.
|
|
|
$3500.00 |
| |
|
|
|
2022 Analysis of Tumor Marker Testing Instrumentation
And Strategic Profiles of Leading Suppliers
This report reviews current instrumentation technologies, and compares features of major automated and semiautomated analyzers used for tumor marker testing.
|
|
|
$3500.00 |
| |
|
|
|
2022 Analysis of Tumor Markers Technologies
And Strategic Profiles of Leading Suppliers
This report provides detailed assessments of such technologies as monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their potential applications for tumor markers technologies. Also included is a review of competing/complementing technologies, such as CT, MRI, NMR, PET and photonics spectroscopy.
|
|
|
$3500.00 |
| |
|
|
|
2022 French Tumor Marker Testing Market Outlook: Innovations, Trends and Opportunities for Suppliers
Highlights - Comprehensive analysis of the French tumor marker testing market.
- Major issues pertaining to the French laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years....
|
|
|
$3500.00 |
| |
|
|
|
|